Interventional Cardiology Devices Market Worth $20.85 Billion by 2022 - Exclusive Report by MarketsandMarkets™

CHICAGO, July 9, 2019 /PRNewswire/ -- According to the new market research report "Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022", published by MarketsandMarkets™, the interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548

Factors driving the growth of this market include technological advancements in interventional cardiology devices, rising geriatric population, increasing incidence of cardiovascular diseases, and improving healthcare infrastructure in emerging markets. 

Angioplasty stents are estimated to account for the largest share of the Interventional Cardiology Devices Market in 2017.

The angioplasty stents market is further segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents. The drug-eluting stents segment is expected to account for the largest share of the global Interventional Cardiology Devices Market in 2017. Factors driving the growth of this segment include the wide range of benefits associated with the use of drug-eluting stents and the widespread availability of these devices across the globe.

Browse in-depth TOC on "Interventional Cardiology Devices Market"

156 – Tables

40 – Figures   

179 – Pages

The plaque modification devices segment is estimated to grow at the highest CAGR during the forecast period.

The plaque modification devices market is further segmented into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is expected to account for the largest share of the global Interventional Cardiology Devices Market in 2017. Market growth can largely be attributed to factors such as the rising incidence of plaque deposition and the increasing demand for technologically advanced thrombectomy devices.

North America is estimated to command the largest share of the market during the forecast period.

Based on region, the Interventional Cardiology Devices Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the Interventional Cardiology Devices Market in 2017. This is mainly due to factors such as the increasing patient base of cardiovascular diseases, technological advancements in interventional cardiology devices, and growing healthcare expenditures.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=548

Key players in the Interventional Cardiology Devices Market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022

Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/minimally-invasive-interventional-cardiology-devices-market.asp 
Visit Our Website: https://www.marketsandmarkets.com 
Content Source: https://www.marketsandmarkets.com/PressReleases/cardiology-devices.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg